| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 162.32M | 153.99M | 141.33M | 86.32M | 69.10M | 57.25M |
| Gross Profit | 145.07M | 146.20M | 134.02M | 77.73M | 64.46M | 52.87M |
| EBITDA | 47.03M | 48.01M | 41.31M | 30.75M | 18.22M | 10.81M |
| Net Income | 38.98M | 33.24M | 26.43M | 25.08M | 15.17M | 6.50M |
Balance Sheet | ||||||
| Total Assets | 167.13M | 167.15M | 153.33M | 98.86M | 78.66M | 52.25M |
| Cash, Cash Equivalents and Short-Term Investments | 48.28M | 43.25M | 45.00M | 54.29M | 39.43M | 13.90M |
| Total Debt | 18.64M | 19.44M | 7.77M | 14.10M | 16.34M | 14.89M |
| Total Liabilities | 79.08M | 81.88M | 64.76M | 40.27M | 38.86M | 31.34M |
| Stockholders Equity | 88.05M | 85.27M | 88.57M | 58.59M | 39.80M | 20.91M |
Cash Flow | ||||||
| Free Cash Flow | 54.92M | 41.69M | 43.88M | 24.50M | 16.32M | 8.24M |
| Operating Cash Flow | 56.02M | 44.12M | 44.67M | 25.07M | 16.47M | 14.25M |
| Investing Cash Flow | -3.05M | -2.94M | -5.65M | -865.00K | 2.78M | 39.73M |
| Financing Cash Flow | -57.30M | -43.38M | -33.78M | -9.35M | 7.18M | -50.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £8.97B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £851.25M | 8.25 | 7.11% | 2.70% | -4.38% | ― | |
73 Outperform | £408.79M | 7.48 | 44.99% | 5.73% | ― | ― | |
71 Outperform | £478.21M | 10.05 | 9.58% | 5.79% | 82.69% | 21.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.47B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
54 Neutral | £2.05B | 56.55 | 4.25% | 2.85% | 62.91% | -15.13% |